Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 9Polycystic Ovary Syndrome 6Colorectal Neoplasms 6Breast Neoplasms 6Obesity 5Weight Loss 4Neoplasms 4Colonic Neoplasms 4Prostatic Neoplasms 3Endometrial Neoplasms 3Overweight 2Multiple Endocrine Neoplasia Type 1 2Malnutrition 2Lymphoma, Follicular 2Carcinoma, Intraductal, Noninfiltrating 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Metabolic Syndrome 1Menstruation Disturbances 1Medical Oncology 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Resistance Training 3Nutritional Status 2Resistant Starch 1Plant Proteins 1Nutrition Assessment 1Methods 1Exercise Movement Techniques 1Exercise 1Ethanol 1Endodontics 1Educational Status 1Early Intervention, Educational 1Diet 1Continuous Glucose Monitoring 1Circuit-Based Exercise 1Cholecalciferol 1Blood Specimen Collection 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Diabetes Mellitus, Type 2 × Diet × Clear all
NCT03206827 2021-09-27

ScenoProt

University of Helsinki

Phase NA Completed
147 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡